Annual report [Section 13 and 15(d), not S-K Item 405]

Stock-Based Compensation - Stock Options Narrative (Details)

v3.25.4
Stock-Based Compensation - Stock Options Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Stock Option Disclosures      
Intrinsic value of options exercised $ 21,204 $ 2,031 $ 1,710
Weighted average period of recognition of unrecognized compensation expense 1 year 2 months 12 days    
Prior Axogen Plan      
Stock Option Disclosures      
Vesting period 10 years    
Stock options      
Stock Option Disclosures      
Weighted average grant date fair value (in USD per share)   $ 4.33 $ 4.72
Unrecognized compensation costs related to non-vested stock options and restricted stock awards $ 697    
Stock options | 2017 ESPP      
Stock Option Disclosures      
Vesting period 4 years    
Stock options | 2017 ESPP | Tranche One      
Stock Option Disclosures      
Vesting percentage 50.00%    
Vesting period 2 years    
Stock options | 2017 ESPP | Tranche Two      
Stock Option Disclosures      
Vesting percentage 12.50%    
Vesting period 2 years    
Directors And Officers Stock Options | 2017 ESPP      
Stock Option Disclosures      
Vesting period 3 years